SCHEMBL30897522

SCHEMBL30897522

CNc1nc2cc(CO[Si](C)(C)C(C)(C)C)ccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL6 P05231 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ MAPT P10636 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ POLB P06746 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ RAF1 P04049 1/20 0.33
▸ BRAF P15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31430559 1.00 IL6 (0.39) IL6STAT3MAPTMEN1KMT2A
SCHEMBL13754403 0.77 IL6 (0.56) IL6STAT3MAPTMEN1KMT2A
SCHEMBL30897548 0.76 IL6 (0.45) IL6STAT3MAPTNPC1RAB9A
SCHEMBL31430628 0.73 RAB9A (0.34) RAB9APOLBALDH1A1
SCHEMBL7371826 0.72 USP14 (0.33) —
SCHEMBL7106525 0.71 IGF1R (0.33) MEN1KMT2ABRAF
SCHEMBL17361958 0.70 APP (0.44) MEN1KMT2AALDH1A1TP53HPGD
SCHEMBL9895355 0.70 PIK3CG (0.45) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23696962 0.70 NPC1 (0.39) IL6STAT3MAPTMEN1KMT2A
SCHEMBL31317095 0.70 USP14 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634175-A1 BENZIMIDAZOLE DERIVATIVES Immvention Therapeutix, Inc. (US) 2025-10-22 — — EP disclosed
WO-2024130173-A1 BENZIMIDAZOLE DERIVATIVES IMMVENTION THERAPEUTIX (US) 2024-06-20 — — WO disclosed
Send feedback